Prevent target safety failures with unique data insights and cutting-edge approaches. Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities. Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.
| Website | https://www.sablebio.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Patient Safety, Drug Safety, Drug Development, Clinical Trials, Clinical Development, Predictive Modeling, Data Insights, Risk Assessment, Trial Optimization, Data Analytics, Big Data Analytics, Advanced Analytics, Biotechnology, Precision Medicine, Regulatory Compliance, Pharmacovigilance, Healthcare Data |
| Competitors | Bristol Myers Squibb, Amgen, Regeneron, Illumina, Corteva Agriscience, Twist Bioscience, Codexis, Inc., Synthego Corporation, Geno, Zymergen, Inc. +41 more (view full list) |
Looking for a particular Sable Bio employee's phone or email?
Sable Bio Questions
Josh Almond-Thynne is the CEO of Sable Bio.
10 people are employed at Sable Bio.
Sable Bio is based in London, England.
Top Sable Bio Employees
-
Olly Oechsle
CTO at Sable Bio
England, United Kingdom21 -
Shannon Johnson
Head of Operations at Sable Bio
United Kingdom1 -
Collin Bantle
Scientific Advisor at Sable Bio
Boston, MA, US13 -
Naomi Cannell
Data Scientist at Sable Bio
London, GB1 -
Subin C.
Data Scientist at Sable Bio
United Kingdom
